New cancer drug shows encouraging results in Phase I/II trial
WEB6 days ago · Results from the first-in-human Phase I/II trial were presented by Funda Meric-Bernstam, M.D., chair of Investigational Cancer Therapeutics. The study included 47 patients with a median age of 57 ...
Experimental mRNA cancer vaccine shows potential for advanced …
WEB6 days ago · The trial continues to recruit patients with melanoma and lung cancer in combination with the immunotherapy drug pembrolizumab to provide more information on the safety and efficacy of the therapy.
Pfizer's cancer cachexia drug shows positive midstage trial results
WEB5 days ago · Pfizer ’s experimental drug for a common, life-threatening condition that causes cancer patients to lose their appetite and weight showed positive results in a midstage trial, the drugmaker said ...
An experimental cancer drug had a 100% success rate : NPR
WEBJun 7, 2022 · A tiny group of people with rectal cancer just experienced something of a scientific miracle: their cancer simply vanished after an experimental treatment.
FDA approves groundbreaking treatment for advanced melanoma - NBC News
WEBThe Food and Drug Administration on Friday approved a new cancer therapy that could one day transform the way a majority of aggressive and advanced tumors are treated.
Cancer-fighting antibodies inject chemo directly into tumor cells ...
WEBJun 2, 2024 · By attaching a chemotherapy drug to an antibody, doctors are able to deliver more potent cancer-fighting medicines directly into tumor cells, all while causing fewer side effects.
Enhertu Approved for Any HER2-Positive Solid Cancer - NCI
WEBMay 3, 2024 · The drug trastuzumab deruxtecan (Enhertu) can now be used to treat a wide variety of cancers, thanks to a new approval from the Food and Drug Administration (FDA).
FDA Approves First Cellular Therapy to Treat Patients with …
WEBFeb 16, 2024 · Today, the U.S. Food and Drug Administration approved Amtagvi, the first cellular therapy indicated for the treatment of adult patients with a type of skin cancer (melanoma) that is unable to...
Lifileucel First Cellular Therapy Approved for Cancer
WEBIn an event more than three decades in the making, the Food and Drug Administration (FDA) has approved lifileucel (Amtagvi), the first treatment for cancer that uses immune cells called tumor-infiltrating lymphocytes, or TILs.
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
WEBJune 7, 2022. The patients had metastatic breast cancer that had been progressing despite rounds of harsh chemotherapy. But a treatment with a drug that targeted cancer cells with laserlike...